BFI CO., LLC sold 40.0% of their position (20K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $942.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/6/2018ACC: 0001144204-18-048380
-20K
Net shares
Net seller
$942.7K
Total sold
3
Open market trades
0B · 3S
5
Total transactions
20K acquired · 40K disposed
Non-Derivative Transactions4
Class A Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
66.7%
9/5/2018
30K→50K
Class A Common Stock
Direct
Shares
−10K
Price / share
$47.30
Trade value
$473K
% of position
20.0%
9/5/2018
50K→40K
Class A Common Stock
Direct
Shares
−9.40K
Price / share
$46.94
Trade value
$441.24K
% of position
23.5%
9/6/2018
40K→30.60K
Class A Common Stock
Direct
Shares
−600.00
Price / share
$47.47
Trade value
$28.48K
% of position
2.0%
9/6/2018
30.60K→30K
Total
Net shares
+0.00
Net value
-$942.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/5/2018 | C · Conversion | +20K | — | — | 66.7% | 30K | 50K |
| Class A Common Stock Direct | 9/5/2018 | S · Sale | −10K | $47.30 | $473K | 20.0% | 50K | 40K |
| Class A Common Stock Direct | 9/6/2018 | S · Sale | −9.40K | $46.94 | $441.24K | 23.5% | 40K | 30.60K |
| Class A Common Stock Direct | 9/6/2018 | S · Sale | −600.00 | $47.47 | $28.48K | 2.0% | 30.60K | 30K |
| Total | +0.00 | -$942.72K | ||||||
Derivative Transactions1
Class B Common Stock
Direct
Converts to
Class A Common Stock
20K shares
Shares
−20K
Strike price
0
Held after
20.20M
Exercisable
—
9/5/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Common Stock Direct | Class A Common Stock20K shares | 9/5/2018 | C · Conversion | −20K | 0 | — | 20.20M |